313 related articles for article (PubMed ID: 1573269)
1. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
Ebanks RO; Isenman DE
J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
[TBL] [Abstract][Full Text] [Related]
3. The coding sequence of the hemolytically inactive C4A6 allotype of human complement component C4 reveals that a single arginine to tryptophan substitution at beta-chain residue 458 is the likely cause of the defect.
Anderson MJ; Milner CM; Cotton RG; Campbell RD
J Immunol; 1992 May; 148(9):2795-802. PubMed ID: 1573268
[TBL] [Abstract][Full Text] [Related]
4. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
5. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
6. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
Ebanks RO; Isenman DE
Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
[TBL] [Abstract][Full Text] [Related]
7. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.
Reilly BD; Levine RP; Skanes VM
J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003
[TBL] [Abstract][Full Text] [Related]
10. A covalent dimer of complement C4b serves as a subunit of a novel C5 convertase that involves no C3 derivatives.
Masaki T; Matsumoto M; Yasuda R; Levine RP; Kitamura H; Seya T
J Immunol; 1991 Aug; 147(3):927-32. PubMed ID: 1861081
[TBL] [Abstract][Full Text] [Related]
11. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
[TBL] [Abstract][Full Text] [Related]
12. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T
Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055
[TBL] [Abstract][Full Text] [Related]
13. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
15. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.
Isenman DE; Young JR
J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717
[TBL] [Abstract][Full Text] [Related]
16. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.
Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY
Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523
[TBL] [Abstract][Full Text] [Related]
17. Regulation and deregulation of the fluid-phase classical pathway C3 convertase.
Gigli I; Sorvillo J; Halbwachs-Mecarelli L
J Immunol; 1985 Jul; 135(1):440-4. PubMed ID: 3158705
[TBL] [Abstract][Full Text] [Related]
18. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of activation of the classical pathway of complement by monoclonal IgE (DES). Restricted regulation of C4b by C4b-binding protein.
Saint-Remy JM
Eur J Immunol; 1984 Mar; 14(3):254-9. PubMed ID: 6608450
[TBL] [Abstract][Full Text] [Related]
20. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
Rawal N; Pangburn MK
Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
